Results 101 to 110 of about 1,531,874 (315)
Systematic reviews of clinical laboratory studies: Pilot risk of bias tool developed by consensus
Cochrane Evidence Synthesis and MethodsIntroduction Some research studies aim to elucidate pathophysiology by examining blood or tissue markers in relation to clinical findings. In COVID‐19, this has led specialists to promote treatment options based on single studies without systematic ...
Tilly Fox +6 more
doaj +1 more source
Environmental risk assessment and the intrusion of bias
Environment International, 2002 The concept of managing the environment and any associated human health impacts by means of such science-based tools as toxicological evaluation, risk assessment, and economic appraisal has become widely accepted in professional circles. These increasingly complex methodologies have not won universal support, however, even among the technically minded,
openaire +2 more sources
FEBS Open Bio, EarlyView.Chemotherapy side effects significantly impact cancer survivors' quality of life. Using protein levels in blood samples from breast cancer patients before and after 12 weeks of taxane treatment, we detected treatment‐dependent changes in calcium signaling and aging pathways associated with cancer recurrence.
Saira Munshani +6 more
wiley +1 more source
An Assessment of the Risk of Bias in Randomized Controlled Trial Reports Published in Prosthodontic and Implant Dentistry Journals [PDF]
, 2015 PURPOSE The objective of this study was to assess the risk of bias of randomized controlled trials (RCTs) published in prosthodontic and implant dentistry journals.
Petridis, Haralampos +8 more
core +1 more source
Avicenna Journal of MedicineIntroduction Case reports and series are critical to guide initial decision-making in a pandemic, but may have lower rigor because of the need to publish them quickly.
Yahya Alsawaf +13 more
doaj +1 more source
Assessing Risk of Bias in Randomized Controlled Trials for Autism Spectrum Disorder
Frontiers in Psychiatry, 2017 AimTo determine construct validity and reliability indicators of the Cochrane risk of bias (RoB) tool in the context of randomized clinical trials (RCTs) for autism spectrum disorder (ASD).MethodsConfirmatory factor analysis was used to evaluate a ...
Paola Matiko Martins Okuda +6 more
doaj +1 more source
Transcripts enriched in codons that trigger P‐site tRNA‐mediated mRNA decay possess stable mRNA
FEBS Open Bio, EarlyView.PTMD codons were first described by Mendel et al. as mediators of an mRNA decay pathway dependent on the human protein CNOT3, homologous to yeast Not5. Our findings confirm that PTMD codons destabilize transcripts; however, unlike in yeast, the human pathway specifically targets and slightly destabilizes primarily stable mRNAs.
Rodolfo Lopes Carneiro +1 more
wiley +1 more source
, 2014 Risk of bias. Red (−): high risk of bias; Yellow (?): unknown risk of bias; Green (+): low risk of bias.
Xia-feng Yang (524991) +4 more
core +1 more source
Risk of bias according to revised Cochrane risk-of-bias tool for randomized trials.
, 2020 Risk of bias according to revised Cochrane risk-of-bias tool for randomized trials.
Pol Chewcharat (8436504) +3 more
core +1 more source
Pathways and pitfalls: a qualitative study of student experiences in biomedical science education
FEBS Open Bio, EarlyView.Biomedical science students from underrepresented backgrounds face barriers including financial strain, disrupted laboratory access and cultural exclusion. Peer networks provide vital support when institutional systems are difficult to navigate. To create inclusive learning environments and achieve academic success, educators should blend active, hands‐
Olivia J. Russell +8 more
wiley +1 more source